Press Release


Colfax Reports Third Quarter 2011 Results

FULTON, Md., Oct. 27, 2011 /PRNewswire/ -- Colfax Corporation (NYSE: CFX), a global leader in fluid-handling solutions for critical applications, today announced financial results for the third quarter ended September 30, 2011. On a year-over-year basis, highlights for the third quarter and year-to-date period include:  

Third Quarter of 2011 (all comparisons versus the third quarter of 2010)

  • Net income of $3.7 million (8 cents per share — basic and diluted); adjusted net income (as defined below) of $16.3 million (37 cents per share), an increase of 71.6%
  • Net sales of $170.3 million, an increase of 28.6%; organic sales increase (as defined below) of 10.4%
  • Operating income of $5.4 million; adjusted operating income (as defined below) of $23.9 million, an increase of 53.2%  
  • Third quarter orders of $174.8 million, an increase of 40.9%; organic order increase (as defined below) of 28.8%  
  • Backlog of $373.4 million at period end

Nine Months Ended September 30, 2011 (all comparisons versus the nine months ended October 1, 2010)

  • Net income of $20.6 million (47 cents per share — basic and diluted); adjusted net income (as defined below) of $40.5 million (91 cents per share), an increase of 73.8%
  • Net sales of $515.6 million, an increase of 37.4%; organic sales increase (as defined below) of 14.0%
  • Operating income of $33.5 million; adjusted operating income (as defined below) of $62.8 million, an increase of 59.8%  
  • Year-to-date 2011 orders of $529.4 million, an increase of 32.6%; organic order increase (as defined below) of 13.3%

Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.

Clay Kiefaber, President and Chief Executive Officer, stated, "We are pleased to announce strong results for the third quarter. Sales growth was driven by broad-based strength in all of our end markets. Order growth exceeded our expectations as growth was robust in all of our end markets on both a total and organic basis. We continue to progress with our restructuring, focused on building a leaner, customer-centric organization that optimizes the potential of a unified Colfax team and expect to begin to realize the cost-savings from our strategic priority projects during 2012. The proposed acquisition of Charter International plc, which was announced during the quarter, will be a transformational acquisition for Colfax that will increase our scale, add a new growth platform and create a truly global industry leader. We are also excited about the balance it provides to our portfolio, which will have revenues approximately evenly distributed between fore- and aftermarket, emerging and developed economies, and short- and long-cycle businesses.

"During the third quarter, we also welcomed Steve Wittig to the organization as SVP of the Colfax Business System and Supply Chain Strategy. Steve is a critical addition to the leadership team and will lead our efforts in enhancing our CBS effectiveness and ensuring that our future leaders have the appropriate skill set to achieve sustained levels of excellence.  He will also be responsible for taking our global supply chain strategy to the next level."    

Non-GAAP Financial Measures and Other Adjustments

Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, earnings before interest, taxes and depreciation (EBITDA), adjusted EBITDA, organic sales growth and organic order growth. Adjusted net income, adjusted net income per share, adjusted EBITDA and adjusted operating income exclude asbestos liability and defense costs and asbestos coverage litigation expenses, restructuring and other related charges, and beginning in Q3 2011, charges related to the proposed Charter acquisition to the extent they impact the periods presented. As we are currently anticipating a reduction in our 2011 adjusted-basis effective tax rate from 32% to 30.5%, the effective tax rates used to calculate adjusted net income and  adjusted net income per share present income taxes are 30.5% and 28.2% for the year to date and Q3 periods of 2011, respectively, in comparison to 32% for both the year to date and Q3 periods of 2010.  Organic sales growth and organic order growth exclude the impact of acquisitions and foreign exchange rate fluctuations.  These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of legacy asbestos issues, costs related to the Charter acquisition and items outside the control of its operating management team.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.

Conference Call and Webcast

Colfax will host a conference call to provide details about its results on Thursday, October 27, 2011 at 8:00 a.m. ET. The call will be open to the public through 877-303-7908 or 678-373-0875 and webcast via Colfax's website at www.colfaxcorp.com under the "Investors" section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading.  Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.

About Colfax Corporation

Colfax Corporation is a global leader in critical fluid-handling products and technologies. Through its global operating subsidiaries, Colfax manufactures positive displacement industrial pumps and valves used in oil & gas, power generation, commercial marine, defense and general industrial markets. Colfax's operating subsidiaries supply products under the well-known brands Allweiler, Baric, Fairmount Automation, Houttuin, Imo, LSC, Portland Valve, Tushaco, Warren and Zenith. Colfax is traded on the NYSE under the ticker "CFX." Additional information about Colfax is available at www.colfaxcorp.com.

CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact, including the expected effects of the proposed Charter acquisition, its anticipated benefits and potential impact on our business. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission including its 2010 Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the period ended September 30, 2011 under the caption "Risk Factors". In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of this date. Colfax disclaims any duty to update the information herein.

The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.

Colfax Corporation
Condensed Consolidated Statements of Operations
Dollars in thousands, except per share data
(Unaudited)



Three Months Ended

Nine Months Ended


September 30,

2011

October 1,

2010

September 30,

2011

October 1,

2010

Net sales                                           

$  170,294

$  132,397

$  515,601

$  375,336

Cost of sales                                        

109,667

85,300

337,046

243,502

Gross profit                                         

60,627

47,097

178,555

131,834

Selling, general and administrative expense                

40,972

29,927

116,920

87,829

Research and development expense                     

1,439

1,583

4,540

4,731

Restructuring and other related charges                   

5,299

2,441

7,518

9,515

Asbestos liability and defense cost                       

4,391

2,202

7,644

4,179

Asbestos coverage litigation expense                    

3,086

2,339

8,454

10,763

Operating income                                     

5,440

8,605

33,479

14,817

Interest expense                                     

1,218

1,544

4,507

5,075

Income before income taxes                            

4,222

7,061

28,972

9,742

Provision for income taxes                             

532

1,210

8,337

2,177

Net income                                         

$         3,690

$          5,851

$      20,635

$        7,565

Net income per share—basic and diluted                  

$           0.08

$            0.13

$          0.47

$          0.17




Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in thousands, except per share data
(Unaudited)



Three Months Ended

Nine Months Ended


September 30,

2011

October 1,

2010

September 30,

2011

October 1,

2010

EBITDA





Net income                                         

$        3,690

$  5,851

$      20,635

$        7,565

Interest expense                                     

1,218

1,544

4,507

5,075

Provision for income taxes                             

532

1,210

8,337

2,177

Depreciation and amortization                           

5,306

3,932

17,426

11,242

EBITDA                                             

$      10,746

$       12,537

$      50,905

$      26,059

EBITDA margin                                       

6.3%

9.5%

9.9%

6.9%






Adjusted EBITDA





Net income                                         

$        3,690

$  5,851

$      20,635

$       7,565

Interest expense                                     

1,218

1,544

4,507

5,075

Provision for income taxes                             

532

1,210

8,337

2,177

Depreciation and amortization                           

5,306

3,932

17,426

11,242

Charter acquisition-related costs                         

5,728

5,728

Restructuring and other related charges                   

5,299

2,441

7,518

9,515

Asbestos liability and defense costs                     

4,391

2,202

7,644

4,179

Asbestos coverage litigation expenses                   

3,086

2,339

8,454

10,763

Adjusted EBITDA                                     

$      29,250

$       19,519

$      80,249

$     50,516

Adjusted EBITDA margin                               

17.2%

14.7%

15.6%

13.5%






Adjusted Operating Income





Operating income                                     

$        5,440

$         8,605

$      33,479

$     14,817

Charter acquisition-related costs                         

5,728

5,728

Restructuring and other related charges                   

5,299

2,441

7,518

9,515

Asbestos liability and defense costs                     

4,391

2,202

7,644

4,179

Asbestos coverage litigation expenses                   

3,086

2,339

8,454

10,763

Adjusted operating income                             

$      23,944

$       15,587

$      62,823

$     39,274

Adjusted operating income margin                       

14.1%

11.8%

12.2%

10.5%






Adjusted Net Income and Adjusted Earnings Per Share





Net income                                         

$        3,690

$  5,851

$      20,635

$       7,565

Restructuring and other related charges                   

5,299

2,441

7,518

9,515

Charter acquisition-related costs                         

5,728

5,728

Asbestos liability and defense costs                     

4,391

2,202

7,644

4,179

Asbestos coverage litigation expenses                   

3,086

2,339

8,454

10,763

Tax adjustment to effective rate(1)                       

(5,865)

(3,284)

(9,449)

(8,767)

Adjusted net income                                  

$      16,329

$         9,549

$      40,530

$     23,255

Adjusted net income margin                             

9.6%

7.2%

7.9%

6.2%






Weighted-average shares outstanding—diluted             

44,411,970

43,619,252

44,299,157

43,539,372

Adjusted net income per share                          

$          0.37

$          0.22

$          0.91

$          0.53






Net income per share—diluted (in accordance with GAAP)   

$          0.08

$          0.13

$          0.47

$          0.17



(1) As we are currently anticipating a reduction in our 2011 adjusted-basis effective tax rate from 32% to 30.5%, the effective tax rates used to calculate adjusted net income and adjusted net income per share present income taxes are 30.5% and 28.2% for the year to date and Q3 periods of 2011, respectively, in comparison to 32% for both the year to date and Q3 periods of 2010.  




Colfax Corporation
Change in Sales, Orders and Backlog
Dollars in millions
(Unaudited)



Net Sales

Orders


$

%

$

%


(In millions)

Three months ended October 1, 2010       

$  132.4


$  124.1


Components of Change:





Existing businesses                     

13.8

10.4 %

35.7

28.8 %

Acquisitions                           

14.9

11.3 %

6.0

4.8 %

Foreign currency translation              

9.2

6.9 %

9.0

7.3 %


37.9

28.6 %

50.7

40.9 %

Three months ended September 30, 2011   

$  170.3


$ 174.8







Net Sales

Orders

Backlog at Period End


$

%

$

%

$

%


(In millions)

As of and for the nine months ended October 1, 2010

$  375.3


$ 399.2


$  351.2


Components of Change:







Existing businesses                    

52.6

14.0 %

53.2

13.3 %

(17.3)

(4.9)%

Acquisitions                          

65.7

17.5 %

55.1

13.8 %

40.6

11.5 %

Foreign currency translation             

22.0

5.9 %

21.9

5.5 %

(1.1)

(0.3)%


140.3

37.4 %

130.2

32.6 %

22.2

6.3 %

As of and for the nine months ended September 30, 2011

$  515.6


$ 529.4


$  373.4





SOURCE Colfax Corporation

News Provided by Acquire Media